Molecular Classification
Receptor, Transporter, Enzyme, Ion channel, Scavenger receptor, Porin, Adhesin, Other
Other Names
Bacterial cell-surface receptor, bacterial membrane receptor, bacterial transmembrane receptor, phage receptor, surface protein, outer membrane protein
Disease Roles
InfectionInflammationAntibiotic resistance

Bacterial surface receptor Overview

Bacterial surface receptors are a heterogeneous group of transmembrane or outer membrane proteins present on the surface of bacterial cells. These receptors serve as points of interaction for environmental molecules, antibiotics, host factors, and bacteriophages. They are essential for ligand binding, signal transduction, nutrient uptake, bacterial adhesion, and virulence, making them a frequent focus for anti-infective drug development and phage therapy[6][2][1][4][8][9]. A single bacterium expresses multiple surface receptors, each of which may have a distinct role in survival, pathogenesis, or resistance. Therapeutic targeting of these receptors is challenged by their diversity, redundancy, ability to mutate, and conservation across pathogenic and commensal species[4][8][6]. For precise drug development, individual surface molecules (e.g., OmpF porin, CD36, PBPs) should be specified.

Mechanism of Action

Inhibition of cell wall biosynthesis via binding to surface proteins (e.g., PBPs targeted by beta-lactams); Disruption of membrane integrity or pore formation; Direct bacteriolysis (phage binding and injection); Inhibition of nutrient uptake or efflux; Blocking signal transduction pathways required for virulence

Biological Functions

Signal transduction
Ligand binding
Cell adhesion
Nutrient uptake
Virulence factor
Host-pathogen interaction
Immune evasion
Biofilm formation
Antibiotic resistance

Disease Associations

Infection
Inflammation
Antibiotic resistance
Pathogenesis
Host colonization

Safety Considerations

  • Poor target specificity when receptors are conserved among commensal bacteria (risk of disrupting the microbiome)
  • Rapid resistance via receptor mutation or loss (bacteria often mutate or shed surface proteins under drug pressure)
  • Immunogenicity or off-target effects in bacteriophage therapies

Interacting Drugs

Beta-lactam antibiotics (e.g., penicillins, cephalosporins)
Glycopeptide antibiotics (e.g., vancomycin, oritavancin)
Fluoroquinolones (targeting DNA gyrase via entry through outer membrane receptors)
Bacteriophage (biologics)
Small molecule inhibitors of surface biosynthesis (research stage)

Associated Biomarkers

Biomarker
Expression of specific surface receptors (e.g., porins, efflux pumps, lipoproteins)
Antibiotic susceptibility (e.g., loss or modification of surface receptor correlates with resistance/sensitivity)